PodcastIntel
Sign in Get Started Free
Cell & Gene: The Podcast
Cell & Gene: The Podcast

Commercialization Learnings with Novartis Gene Therapies' President Chris Fox

Sep 1, 2022 · 19m
✨ AI Summary
  • Novartis Gene Therapies President Chris Fox discusses commercialization strategies for gene therapies.
  • The focus is on newborn screenings as a pathway to reach more patients.
  • Zolgensma's global success and future commercialization plans are highlighted.

Guests on This Episode

More from Cell & Gene: The Podcast

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Cell & Gene: The Podcast and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →